resorcinol Report issue

Small molecule Experimental
ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Resorcinol Acetate is used as an ingredient to reduce the number of acne blemishes, acne pimples, blackheads, and whiteheads. In the United States, anti-acne agents are regulated as Over-the-Counter (OTC) drug ingredients. Resorcinol Acetate is also used to enhance the appearance and feel of hair, by increasing hair body, suppleness, or sheen, or by improving the texture of hair that has been damaged physically or by chemical treatment and to enhance the appearance of dry or damaged skin by reducing flaking and restoring suppleness.   NCATS

Chemistry

  • SMILES: CC(=O)OC1=CC=CC(O)=C1
  • InChIKey: ZZPKZRHERLGEKA-UHFFFAOYSA-N
  • Mol. Mass: 152.1473
  • ALogP: 1.1
  • ChEMBL Molecule:
    resorcinol  
More Chemistry

Pharmacology

Alternative names

benzene-1,3-diol | d.d.d. | eskamel | resorcin | resorcinol | resorcinol disodium salt | resorcinol, monocopper (2+) salt | tilloderm

Organizations (2)

Research & Development (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (3)

Approved Indications (2)


 

Acne Vulgaris (approved 1991)

Psoriasis (approved 1989)

Experimental Indications - Clinical Trial Phases 1-4 (1)


 

Keratosis, Actinic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial Organizations: 2

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue